lioresal 10 mg tabletti
novartis finland oy - baclofen - tabletti - 10 mg - baklofeeni
lioresal 25 mg tabletti
novartis finland oy - baclofen - tabletti - 25 mg - baklofeeni
baklofen mylan 10 mg tabletti
mylan ab - baclofen - tabletti - 10 mg - baklofeeni
baklofen mylan 25 mg tabletti
mylan ab - baclofen - tabletti - 25 mg - baklofeeni
phelinun
adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - antineoplastiset aineet - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.
terolut 10 mg tabletti, kalvopäällysteinen
viatris oy - dydrogesterone - tabletti, kalvopäällysteinen - 10 mg - dydrogesteroni
hiprabovis somni/lkt injektioneste, emulsio
laboratorios hipra s.a. - mannheimia haemolytica, leukotoxoid, serotype a1, inactivated, histophilus somni, bailie strain, inactivated - injektioneste, emulsio
kexxtone
elanco gmbh - monensiini (monensiinina natriumina) - huumeiden ehkäisyyn ja/tai hoitoon acetonemia - nauta (lehmät ja hiehot) - ketoosin esiintyvyyden väheneminen periaihalla lypsykarjalle / hiehoon, jonka odotetaan kehittävän ketoosia.
scheriproct neo rektaalivoide
karo pharma ab - cinchocaine hydrochloride, prednisolone caproate - rektaalivoide - prednisoloni
scheriproct neo kombi -yhdistelmäpakkaus peräpuikko ja rektaalivoide
karo pharma ab - cinchocaine hydrochloride, prednisolone caproate - peräpuikko ja rektaalivoide - prednisoloni